Endothelial dysfunction in different stages of diseases severity of COVID-19: focus on endocan and arterial hypertension
Background: Endocan, an endothelial dysfunction marker, recently emerged as a risk-stratification and prognostic marker in cardiovascular and respiratory diseases, but remains seldom explored in COVID-19. We evaluated endocan and other endothelial activation markers in hospitalized COVID-19 patients...
| Autor principal: | |
|---|---|
| Formato: | masterThesis |
| Idioma: | eng |
| Publicado em: |
2022
|
| Assuntos: | |
| Texto completo: | https://hdl.handle.net/10216/142133 |
| País: | Portugal |
| Oai: | oai:repositorio-aberto.up.pt:10216/142133 |